Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FKMZK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,609
Award facts
- Contract value 100% obligated
- $71,609.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $71,609.11 for Descovy 200-25 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award, effective August 1, 2025 with an ultimate completion date of August 4, 2025, represents a pharmaceutical supply delivery to support federal medical procurement needs. The delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial ceiling value of $999,999,999.00 through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements and serve various federal customers including the Defense Health Agency and U.S. Coast Guard. Descovy, an antiretroviral medication, represents one component of the company's diverse pharmaceutical offerings delivered through the DLA Medical Supply Chain to support military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FKMZK?
SPE2DB25FKMZK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FKMZK worth?
The government has obligated $71,609 on SPE2DB25FKMZK.
Is contract SPE2DB25FKMZK an order under another contract?
Yes. SPE2DB25FKMZK is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKMZK competed?
The extent of competition for SPE2DB25FKMZK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award